CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,314,000 | -45.5% | 6,637,222 | +24.2% | 0.00% | -50.0% |
Q3 2018 | $2,410,000 | -3.1% | 5,343,599 | +22.1% | 0.00% | +100.0% |
Q2 2018 | $2,486,000 | +590.6% | 4,375,101 | +2733.4% | 0.00% | – |
Q1 2018 | $360,000 | -37.4% | 154,414 | -23.3% | 0.00% | -100.0% |
Q3 2017 | $575,000 | -33.2% | 201,214 | -42.3% | 0.00% | 0.0% |
Q2 2017 | $861,000 | -86.0% | 348,614 | -79.6% | 0.00% | -88.9% |
Q1 2017 | $6,166,000 | +45.2% | 1,707,927 | +42.4% | 0.01% | +28.6% |
Q4 2016 | $4,247,000 | -16.4% | 1,199,710 | -4.6% | 0.01% | -22.2% |
Q3 2016 | $5,083,000 | +49.1% | 1,258,214 | +62.0% | 0.01% | +50.0% |
Q2 2016 | $3,410,000 | +10.9% | 776,800 | -4.5% | 0.01% | 0.0% |
Q1 2016 | $3,074,000 | – | 813,331 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KLP Enterprises, LLC | 6,865,006 | $16,957,000 | 100.00% |
Meditor Group Ltd | 5,800,000 | $14,326,000 | 2.16% |
TSP Capital Management Group, LLC | 1,135,748 | $2,805,000 | 1.29% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 8,526,619 | $21,061,000 | 0.30% |
Marcus Capital, LLC | 103,800 | $256,000 | 0.22% |
Benchmark Capital Advisors | 64,800 | $160,000 | 0.13% |
Vident Investment Advisory, LLC | 480,018 | $1,186,000 | 0.10% |
Bellevue Group AG | 160,000 | $395,000 | 0.05% |
NJ State Employees Deferred Compensation Plan | 100,000 | $247,000 | 0.05% |
Virtus ETF Advisers LLC | 126,989 | $314,000 | 0.05% |